Sleep Apnea Control Persists for Some After Stopping Device
A new study suggests that a vibrating device may help some patients with positional obstructive sleep apnea (POSA) maintain disease control even after stopping its use. Approximately one third of patients continued to show improvement three months post-treatment, indicating potential long-term benefits from behavior adaptation. Researchers advocate for personalized treatment approaches based on individual patient characteristics.
- ▪A study presented at the ATS 2026 International Conference found that some patients with POSA maintained disease control after stopping a vibrating device.
- ▪About one third of patients continued to show improvement three months after treatment cessation.
- ▪The study involved 184 patients, with a significant difference in response rates between those using CPAP and those using the positional device.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/sleep-apnea-control-persists-some-after-stopping-device-2026a1000ggz?src=rss |
| Publication time | Thu, 21 May 2026 07:44:56 EDT |
| Retrieval time | 2026-05-21T11:51:11.072Z |
| Last seen | 2026-05-21T11:51:11.072Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | LJe6ATodJj5O |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
A vibrating device may help some patients with a form of obstructive sleep apnea (OSA), even after stopping use, according to a new study presented at the American Thoracic Society (ATS) 2026 International Conference in Orlando, Fla.Positional OSA (POSA) primarily occurs in the supine position. After 6 months of positional therapy, approximately one third of patients maintained disease control 3 months after stopping the device, suggesting behavior adaptation can persist over time, researchers said.“Instead of treating all patients according to the same model, we should identify the mechanism or phenotype driving the disease and select the most appropriate therapy,” said Irene Cano Pumarega, MD, PhD, pulmonologist and head of the Sleep Unit at Ramón y Cajal Hospital in Madrid, Spain, who…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
